Focus Partners Advisor Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Focus Partners Advisor Solutions's BMY Position: Q1 2026 in Review
Focus Partners Advisor Solutions reduced its Bristol-Myers Squibb (BMY) stake by 8.9% in Q1 2026, selling an estimated $694K and leaving 122,407 shares worth $7.42M. The position accounts for 0.07% of the portfolio, ranked #125.
Focus Partners Advisor Solutions first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Focus Partners Advisor Solutions held 122,407 shares of Bristol-Myers Squibb worth $7.42M as of Q1 2026.
- Focus Partners Advisor Solutions sold 11,900 Bristol-Myers Squibb shares in Q1 2026, an estimated $694K.
- Bristol-Myers Squibb made up 0.07% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #125 holding.
- Focus Partners Advisor Solutions first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.